Nationwide recall issued for thousands of blood pressure medication bottles after quality test failure

Patients taking blood pressure medicine may want to inspect their medicine cabinets after thousands of bottles of a prescription drug were recalled across the country.

New Jersey-based Macleods Pharma USA is recalling certain lots of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablets after the drug did not meet federal quality standards, according to the U.S. Food and Drug Administration (FDA).

The recall involves 3,528 30-count bottles from lot 12251163A and 216 90-count bottles from lot 12251163B. Both lots carry an expiration date of May 31, 2027.

Consumers can review their prescription bottles for the lot number and National Drug Code, or NDC. The recalled 30-count bottles have NDC 33342-246-07, while the 90-count bottles have NDC 33342-246-10.

The FDA said the recall was prompted by “failed dissolution specifications,” meaning the tablets did not dissolve properly during testing.

The agency classified the recall as Class II, which means use of the affected product may lead to temporary or medically reversible health effects, while the chance of serious harm is considered remote.

Macleods Pharma USA began the recall in early October, and the FDA later classified it as a recall. The action is still ongoing and affects products distributed nationwide.

The recall follows another blood pressure drug being pulled from the market after a similar problem.

Earlier, India-based Inventia Healthcare Ltd. recalled 13,567 bottles of 25-milligram chlorthalidone tablets after the medication failed dissolution testing, according to the FDA.

Chlorthalidone is used to treat high blood pressure and fluid retention, according to Mayo Clinic.

Macleods Pharma USA did not immediately respond to FOX Business’ request for comment.